Lessons from the ebola outbreak: Action items for emerging infectious disease preparedness and response

EcoHealth

Volumn 13, Issue 1, 2016, Pages 200-212

  Jacobsen, Kathryn H ^a   Alonso Aguirre, A ^a   Bailey, Charles L ^b   Baranova, Ancha V ^a,b   Crooks, Andrew T ^a   Croitoru, Arie ^a   Delamater, Paul L ^a   Gupta, Jhumka ^a   Kehn Hall, Kylene ^b   Narayanan, Aarthi ^b   Pierobon, Mariaelena ^b   Rowan, Katherine E ^a   Reid Schwebach, J ^a   Seshaiyer, Padmanabhan ^a   Sklarew, Dann M ^a   Stefanidis, Anthony ^a   Agouris, Peggy ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

Ebola infection; Emerging infectious diseases; Epidemics; One health; Public health; Surveillance

Indexed keywords

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; GLOBAL HEALTH; HEMORRHAGIC FEVER, EBOLA; HUMAN; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; GLOBAL HEALTH; HEMORRHAGIC FEVER, EBOLA; HUMANS; PUBLIC HEALTH;

EID: 84975709273     PISSN: 16129202     EISSN: 16129210     Source Type: Journal    
DOI: 10.1007/s10393-016-1100-5     Document Type: Review

References (72)

1. Alexander KA, Sanderson CE, Marathe M, Lewis BL, Rivers CM, Shaman J, et al. (2015) What factors might have led to the emergence of Ebola in West Africa? PLoS Neglected Tropical Diseases 9:e0003652. doi:10.1371/journal.pntd.0003652
2. Anyamba A, Chretien JP, Small J, Tucker CJ, Formenty PB, Richardson JH, et al. (2009) Prediction of a Rift Valley fever outbreak. Proceedings of the National Academy of Sciences of the United States of America 106:955-959. doi:10.1073/pnas.0806490106
3. Bausch DG, Schwarz L (2014) Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLoS Neglected Tropical Diseases 8:e3056. doi:10.1371/journal.pntd.0003056
4. Brookes VJ, Hernández-Jover M, Black PF, Ward MP (2015) Preparedness for emerging infectious diseases: pathways from anticipation to action. Epidemiology & Infection 143:2043-2058. doi:10.1017/S095026881400315X
5. Burgner D, Jamieson SE, Blackwell JM (2006) Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infectious Diseases 6:653-663. doi:10.1016/S1473-3099(06)70601-6
6. Burkle FM (2015) Global health security demands a strong International Health Regulations treaty and leadership from a highly resourced World Health Organization. Disaster Medicine and Public Health Preparedness 9:568-580. doi:10.1017/dmp. 2015.26
7. Chevalier MS, Chung W, Smith J, Weil LM, Hughes SM, Joyner SN, et al. (2014) Ebola virus disease cluster in the United States: Dallas County, Texas, 2014. MMWR Morbidity and Mortality Weekly Report 63:1087-1088
8. Choi WY, Hong KJ, Hong JE, Lee WJ (2015) Progress of vaccine and drug development for Ebola preparedness. Clinical and Experimental Vaccine Research 4:11-16. doi:10.7774/cevr.2015.4.1.11
9. Clementi N, Criscuolo E, Casterlli M, Clementi M (2012) Broadrange neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. New Microbiologica 35:399-406
10. Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, Wallace GS (2015) Measles—United States, January 4-April 2, 2015. MMWR Morbidity and Mortality Weekly Report 64:373-376
11. Cohen J, Kupferschmidt K (2014) Ebola vaccine trials raise ethical issues. Science 346:289-290. doi:10.1126/science.346.6207.289
12. Croitoru A, Crooks A, Radzikowski J, Stefanidis A (2013) Geospatial gauge: a system prototype for knowledge discovery from social media. International Journal of Geographical Information Science 27:2483-2508. doi:10.1080/13658816.2013.825724
13. Decker BK, Sevransky JE, Barrett K, Davey RT, Chertow DS (2014) Preparing for critical care services to patients with Ebola. Annals of Internal Medicine 161:831-832. doi:10.7326/M14-2141
14. Delwart E (2012) Animal virus discovery: improving animal health, understanding zoonoses, and opportunities for vaccine development. Current Opinion in Virology 2:344-352. doi:10.1016/j.coviro.2012.02.012
15. Despommier D, Ellis BR, Wilcox BA (2006) The role of ecotones in emerging infectious diseases. EcoHealth 3:281-289. doi:10.1007/s10393-006-0063-3
16. Dixon MA, Dar OA, Heymann DL (2014) Emerging infectious diseases: opportunities at the human-animal-environment interface. Veterinary Record 174:546-551. doi:10.1136/vr.g3263
17. Enserink M (2014) Infectious diseases: debate erupts on ‘‘repurposed’’ drugs for Ebola. Science 345:718-719. doi:10.1126/science. 345.6198.718
18. Ezenwa VO, Prieur-Richard AH, Roche B, Bailly X, Becquart P, García-Peña GE, et al. (2015) Interdisciplinarity and infectious diseases: an Ebola case study. PLoS Pathogens 11:e1004992. doi:10.1371/journal.ppat.1004992
19. Ginsburg GS, Woods CW (2012) The host response to infection: advancing a novel diagnostic paradigm. Critical Care 16:168. doi:10.1186/cc11685
20. Gonsalves G, Staley P (2014) Panic, paranoia, and public health: the AIDS epidemic’s lessons for Ebola. New England Journal of Medicine 371:2348-2349. doi:10.1056/NEJMp1413425
21. Goodwin R, Schley D, Lai KM, Ceddia GM, Barnett J, Cook N (2012) Interdisciplinary approaches to zoonotic disease. Infectious Disease Reports 4:e37. doi:10.4081/ird.2012.e37
22. Gortazar C, Reperant LA, Kuiken T, de la Fuente J, Boadella M, Martínez-Lopez B, et al. (2014) Crossing the interspecies barrier: opening the door to zoonotic pathogens. PLoS Pathogens 10:e1004129. doi:10.1371/journal.ppat.1004129
23. Gostin LO (2014) Ebola: towards an International Health Systems Fund. Lancet 384:e49-e51. doi:10.1016/S0140-6736(14)61345-3
24. Hagan JE, Smith W, Pillai SK, Yeoman K, Gupta S, Neatherlin J, et al. (2015) Implementation of Ebola case-finding using a village chieftaincy taskforce in a remote outbreak—Liberia, 2014. MMWR Morbidity and Mortality Weekly Report 64:183-185
25. Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. (2015) Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomized trial. Lancet 386:857-866. doi:10.1016/S0140-6736(15)61117-5
26. Househ M (2015) Communicating Ebola through social media and electronic news media outlets: a cross-sectional study. Health Informatics Journal. doi:10.1177/1460458214568037
27. Huff AR, Winnebah T (2015) Ebola, politics and ecology: Beyond the ‘‘Outbreak Narrative.’’ Institute of Development Studies (IDS) Practice Paper in Brief 20
28. Hyatt A, Aguirre AA, Jeggo M, Woods R (2015) Effective coordination and management of emerging infectious diseases in wildlife. EcoHealth 12:408-411. doi:10.1007/s10393-015-1045-0
29. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P (2008) Global trends in emerging infectious diseases. Nature 451:990-993. doi:10.1038/nature06536
30. Kahan DM (2013) A risky science communication environment for vaccination. Science 42:53-54. doi:10.1126/science.1245724
31. Kamal SM, Rashid AK, Bakar MA, Ahad MA (2011) Anthrax: an update. Asian Pacific Journal of Tropical Biomedicine 1:496-501. doi:10.1016/S2221-1691(11)60109-3
32. Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA, Bennett M, et al. (2012) Ecology of zoonoses: natural and unnatural histories. Lancet 380:1936-1945. doi:10.1016/S0140-6736(12)61678-X
33. Kasperson RE, Renn O, Slovic P, Brown HS, Emel J, Goble R, et al. (1988) The social amplification of risk: a conceptual framework. Risk Analysis 8:177-187. doi:10.1111/j.1539-6924.1988.tb01168.x
34. Kilmarx PH, Clarke KR, Dietz PM, Hamel MJ, Husain F, McFadden JD, et al. (2014) Ebola virus disease in health care workers: Sierra Leone, 2014. MMWR Morbidity and Mortality Weekly Report 63:1168-1171
35. Kimball AM, Heymann D (2014) Ebola, International Health Regulations, and global safety. Lancet 384:2023. doi:10.1016/S0140-6736(14)62330-8
36. Lowe JJ, Gibbs SG, Schwedhelm S, Nguyen J, Smith PW (2015) Nebraska Biocontainment Unit perspective on disposal of Ebola medical waste. American Journal of Infection Control 42:1256-1257. doi:10.1016/j.ajic.2014.10.006
37. Martin P, Laupland KB, Frost EH, Valiquette L (2015) Laboratory diagnosis of Ebola virus disease. Intensive Care Medicine 41:895-898. doi:10.1007/s00134-015-3671-y
38. Mbonye AK, Wamala JF, Nanyunja M, Opio A, Makumbi I, Aceng JR (2014) Ebola viral hemorrhagic disease outbreak in West Africa: lessons from Uganda. African Health Sciences 14:495-501. doi:10.4314/ahs.v14i3.1
39. Morse SS, Mazet JAK, Woolhouse M, Parrish CR, Carroll D, Karesh WB, et al. (2012) Prediction and prevention of the next pandemic zoonosis. Lancet 380:1956-1965. doi:10.1016/S0140-6736(12)61684-5
40. Munro CL, Savel RH (2015) Viral outbreaks in an age of global citizenship. American Journal of Critical Care 24:4-6. doi:10.4037/ajcc2015809
41. Nielsen CF, Kidd S, Sillah ARM, Davis E, Mermin J, Kilmarx PH (2015) Improving burial practices and cemetery management during an Ebola virus disease epidemic—Sierra Leone, 2014. MMWR Morbidity and Mortality Weekly Report 64:20-27
42. O’Donovan J, Bersin A (2015) Controlling Ebola through mHealth strategies. Lancet Global Health 3:e22. doi:10.1016/S2214-109X(14)70357-2
43. Odlum M, Yoon S (2015) What can we learn about the Ebola outbreak from tweets? American Journal of Infection Control 43:563-571. doi:10.1016/j.ajic.2015.02.023
44. Oyeyemi SO, Gabarron E, Wynn R (2014) Ebola, Twitter, and misinformation: a dangerous combination? BMJ 349:g6178. doi:10.1136/bmj.g6178
45. Paton DJ, Valarcher JF, Bergmann I, Matlho OG, Zakharov VM, Palma EL, Thomson GR (2005) Selection of foot and mouth disease vaccine strains: a review. Revue Scientifique et Technique 24:981-993
46. Pandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, et al. (2014) Strategies for containing Ebola in West Africa. Science 346:991-995. doi:10.1126/science.1260612
47. Patz JA, Daszak P, Tabor GM, Aguirre AA, Pearl MC, Epstein J, et al. (2004) Unhealthy landscapes: policy recommendations pertaining to land use change and disease emergence. Environmental Health Perspectives 112:1092-1098
48. Pigott DM, Golding N, Mylne A, Huang Z, Henry AJ, Weiss DJ, et al. (2014) Mapping the zoonotic niche of Ebola virus disease in Africa. Life 3:e04395. doi:10.7554/eLife.04395
49. Princhard MN, Kern ER (2012) Orthopoxvirus targets for the development of new antiviral agents. Antiviral Research 94:111-125. doi:10.1016/j.antiviral.2012.02.012
50. Prussia A, Thepchatri P, Snyder JP, Plemper RK (2011) Systematic approaches towards the development of host-directed antiviral therapeutics. International Journal of Molecular Sciences 12: 4027-4052. doi:10.3390/ijms12064027
51. Prüss-Üstün A, Corvalán C (2007) How much disease burden can be prevented by environmental interventions? Epidemiology 18:167-178. doi:10.1097/01.ede.0000239647.26389.80
52. Reed PE, Mulangu S, Cameron KN, Ondzie AU, Joly D, Bermejo M, et al. (2014) A new approach for monitoring ebolavirus in wild great apes. PLoS Neglected Tropical Diseases 8:e3143. doi:10.1371/journal.pntd.0003143
53. Rid A, Emanuel EJ (2014) Why should high-income countries help combat Ebola? JAMA 312:1297-1298. doi:10.1001/jama. 2014.12869
54. Rothstein MA (2015) The moral challenge of Ebola. American Journal of Public Health 105:6-8. doi:10.2105/AJPH.2014.302413
55. Ryan SJ, Walsh PD (2011) Consequences of non-intervention for infectious disease in African great apes. PLoS One 6:29030. doi:10.1371/journal.pone.0029030
56. Saéz AM, Weiss S, Nowak K, Lapeyre V, Zimmermann F, Düx A, et al. (2015) Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Molecular Medicine 7:17-23. doi:10.15252/emmm.201404792
57. Sautto G, Mancini N, Gorini G, Clementi M, Burioni R (2013) Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections. BioMed Research International 2013:848491. doi:10.1155/2013/838491
58. Schiavo R, May Leung M, Brown M (2014) Communicating risk and promoting disease mitigation measures in epidemics and emerging disease settings. Pathogens and Global Health 108:76-94. doi:10.1179/2047773214Y.0000000127
59. Spencer C (2015) Having and fighting Ebola: public health lessons from a clinician turned patient. New England Journal of Medicine 372:1089-1091. doi:10.1056/NEJMp1501355
60. Stamm LV (2015) Ebola virus disease: rapid diagnosis and timely case reporting are critical to the early response for outbreak control. American Journal of Tropical Medicine and Hygiene 93:438-440. doi:10.4269/ajtmh.15-0229
61. Stevens KB, Pfeiffer DU (2015) Sources of spatial animal and human health data: casting the net wide to deal more effectively with increasingly complex disease problems. Spatial and Spatiotemporal Epidemiology 13:15-29. doi:10.1016/j.sste.2015.04.003
62. Stothard JR, Adams E (2014) A preface on advances in diagnostics for infectious and parasitic diseases: detecting parasites of medical and veterinary importance. Parasitology 141:1781-1788. doi:10.1017/S0031182014001309
63. Vanderford ML (2015) Emergency risk communication: reflections on a year of accelerating global engagement. Spectra: The Magazine of the National Communication Association 51:8-12
64. Wang SF, Tseng SP, Yen CH, Yang JY, Tsao CH, Shen CW, et al. (2014) Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochemical and Biophysical Research Communications 451:208-214. doi:10.1016/j.bbrc.2014.07.090
65. Welburn SC, Beange I, Ducrotory MJ, Okello AL (2015) The neglected zoonoses: the case for integrated control and advocacy. Clinical Microbiology and Infection 21:433-443. doi:10.1016/j.cmi.2015.04.011
66. Wilcox BA, Ellis B (2006) Forests and emerging infectious diseases of humans. Unasylva 57:11-18
67. Wilkinson A, Leach M (2015) Briefing: Ebola myths, realities, and structural violence. African Affairs 114:136-148. doi:10.1093/afraf/adu080
68. Winerman L (2009) Social networking: crisis communication. Nature 457:376-378. doi:10.1038/457376a
69. Yen CW, de Puig H, Tam JO, Gómez-Márquez J, Bosch I, Hamad-Schifferli K, Gehrke L (2015) Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses. Lab on a Chip 15:1638-1641. doi:10.1039/c5lc00055f
70. Zhou Y, Vendantham P, Lu K, Agudelo J, Carrion R, Nunneley JW, et al. (2015) Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Research 116:76-84. doi:10.1016/j.antiviral. 2015.01.011
71. Zinsstag J, Mackenzie JS, Jeggo M, Heymann DL, Patz JA, Daszak P (2012) Mainstreaming one health. EcoHealth 9:107-110. doi:10.1007/s10393-012-0772-8
72. Zinszer K, Morrison K, Anema A, Majumder MS, Brownstein JS (2015) The velocity of Ebola spread in parts of West Africa. Lancet Infectious Diseases 15:1005-1007. doi:10.1016/S1473-3099(15)00234-0